期刊文献+

Cystatin C与原发性高血压靶器官损伤的关系 被引量:2

Role of serum Cystatin C on organ damage in patients with essential hypertension
下载PDF
导出
摘要 目的探讨血清半胱氨酸蛋白酶抑制剂C(Cystatin C)与原发性高血压靶器官损伤的关系。方法以原发性高血压患者60例为研究对象,采用颗粒增强透射免疫比浊法测量Cystatin C水平,超声波图像评估左心室质量指数(LVMI),无创性袖带式动态血压监测仪测量24 h血压(24 h-BP)。结果血清Cystatin C水平与肌酐清除率、尿微量白蛋白、24 h平均收缩压(24 h-SBP)、LVMI均相关。尿白蛋白排泄率(AER)及血清Cystatin C水平与平均24 h-SBP独立相关。AER与高密度脂蛋白胆固醇相关,而Cystatin C与之不相关。结论血清Cystatin C水平是原发性高血压患者靶器官损伤严重性的一个早期标志。 Objective To observe the role of serum Cystatin C on organ damage in patients with essential hypertension.Methods Sixty patients with essential hypertension were included in the study.Serum Cystatin C level was measured by using particle-enhanced turbidimetric assay.Left ventricular mass index(LVMI) was evaluated by using ultrasound images.Cuff-oscillometric method was adopted to measure 24-hour blood pressure.Results Serum Cystatin C level was correlated with creatinine clearance,urine microamoun albuminuria,mean 24 h systolic blood pressure(24 h-SBP) and LVMI.Both albumin excretion rate(AER) and serum Cystatin C level were independently correlated with mean 24 h-SBP.AER was correlated with HDL-cholesterol.Conlusion Serum Cystatin C level is an early marker to predict the severity of end-organ damage in patients with essential hypertension.
机构地区 安徽医科大学
出处 《山东医药》 CAS 北大核心 2009年第52期37-39,共3页 Shandong Medical Journal
关键词 高血压 CYSTATIN C 蛋白尿 肥大 左心室 hypertension Cystatin C albuminuria hypertrophy,left ventricular
  • 相关文献

参考文献9

  • 1崔蒙,刘加芳,杨清萍,徐金英,刘建迪.高血压病患者血清半胱氨酸蛋白酶抑制剂C测定的临床意义[J].浙江医学,2006,28(5):334-335. 被引量:6
  • 2Ljungman S,Wikstrand J,Hartford M,et al.Urinary albumin ex-cretion-a predictor of risk of cardiovascular disease:a prospective10-year follow-up of middle-aged nondiabetic normal and hyperten-sive men. American Journal of Hypertension . 1996
  • 3Halacova M,Kotaska K,Kukacka J,et al.Serum Cystatin C levelfor better assessment of glomerular filtration rate in cystic firrosis pa-tients treated by amikacin. Journal of Clinical Pharmacy and Therapeutics . 2008
  • 4Laterza O F,Price C P,Scott M G,et al.Cystatin C: an improved estimator of glomerular filtration rate. Clinical Chemistry . 2002
  • 5Ruilope LM,Salvetti A,Jamerson K,et al.Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. Journal of the American Society of Nephrology . 2001
  • 6Mykkanen L,Zaccaro DJ,Wagenkencht LE,et al.Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes . 1998
  • 7Pontremoli R,Ravera M,bezante GP,et al.Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. Journal of Hypertension . 1999
  • 8Strevens H,Wide-Swensson D,Torffvit O,et al.Serumcystatin Cfor assessment of glomerular filtration rate in pregnant and non-pregnant women Indications of alteredfiltration processin pregnancy. ScandJ Clin LabInvest . 2002
  • 9TAMBA K,KUSANO E,ANDO Y.Prospective evaluation of renal function by serum cystatin-C:comparison with three other parameters of glomerular filtration rate. Nippon Jinzo Gakkai Shi . 2001

二级参考文献4

  • 1Coll E,Botey A,Alvarez L,et al.Serum cystatin C as new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J].Am J Kidney Dis,2000,36(1):29.
  • 2Fliser D,Ritz E.Serum cystatin C concentration as a marker of renal dysfunction in the elderly[J].Am J Kidney Dis,2001,37(1):79.
  • 3Newman DJ,Thakkar H,Edwards RG,et al.Serum cystatin C measured by automated immunoassay:a more sensitive marker of changes in GFR than seaum creatinine[J].Kidney Int,1995,47(1):312.
  • 4赵子秀.血清胱蛋白酶抑制剂C测定的临床意义[J].国外医学(泌尿系统分册),2002,22(2):103-104. 被引量:42

共引文献5

同被引文献22

  • 1王湘娟,马卫红,朱桂香,许晓茹,田莉,许晓云,史亚黎.高血压病患者早期肾功能损害与动态血压变异性的临床分析[J].陕西医学杂志,2005,34(4):501-502. 被引量:2
  • 2Bj3rklund K, Lind L, Zethelius B, et al. Prognostic signifi-cance of 24 h ambulatory blood pressure characteristics forcardiovascular morbidity in a population of elderly men[J].J Hypertens,2004,22(9) :1 691 -1 697.
  • 3中国髙血压防治指南修订委员会.中国高血压防治指南(2010年修订版)[J].中国高血压病杂志,2011,12(8):701 -708.
  • 4Mancia G,Parati G. Ambulatory blood pressure monitoring andoi^an damage[J]. Hypertension,2010,36(50) :894 -900.
  • 5Manios E, Tsaqalis G, Tsivqoulis G, et al. Time rate ofblood pressure variation is associated with impaired renalfunction in hypertensive patients [ J ] . J Hypertens ,2009,27(11):2 244 - 2 248.
  • 6Mancia G, Grassi G. Mechanisms and clinical implicationsof blood pressure variability [ J ] . J Cardiovasc Pharmacol,2010,35(7) :815 -819.
  • 7Rothwell PM. Limitations of the usual-blood pressure hypoth-esis and importance of variability, instability, and episodichypertension[ J]. Lancet,2010,375(9 718) :938 -948.
  • 8中华医学会老年医学学会对健康老年人标准的建议(修订草案,1995年)[J].中华老年医学会杂志,1996,15,9.
  • 9National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].Am J Kidney Dis,2002,39(Suppl 2):S1-246.
  • 10Watanabe S,Okra T,Liu J,et al.Serum cystain C level is a marker of end-organ damage in patients with essential hypertension[J].Hypertens Res,2003,26:895-899.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部